SCHEMBL17431195

SCHEMBL17431195

c1ccc2c(c1)oc1ccc3c(c12)-c1cc2c(cc1-c1cc4sc5ccccc5c4cc1-c1c-3ccc3oc4ccccc4c13)sc1ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 1/20 0.39
▸ MAPT P10636 7/20 0.39
▸ ALDH1A1 P00352 5/20 0.39
▸ POLB P06746 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ HPGD P15428 4/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ KDM4E B2RXH2 3/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ MAOA P21397 2/20 0.32
▸ GLA P06280 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ PGAM1 P18669 1/20 0.32
▸ CASP1 P29466 1/20 0.32
▸ CASP7 P55210 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17431204 1.00 GPR3 (0.39) GPR3MAPTALDH1A1POLBTDP1
SCHEMBL17431199 0.82 MAPT (0.40) GPR3MAPTALDH1A1POLBTDP1
SCHEMBL17431200 0.82 MAPT (0.40) GPR3MAPTALDH1A1POLBTDP1
SCHEMBL17431188 0.82 AHR (0.47) GPR3MAPTALDH1A1POLBTDP1
SCHEMBL17433186 0.82 AHR (0.47) GPR3MAPTALDH1A1POLBTDP1
SCHEMBL17431203 0.82 AHR (0.47) GPR3MAPTALDH1A1POLBTDP1
SCHEMBL17431186 0.81 AHR (0.41) GPR3MAPTALDH1A1POLBTDP1
SCHEMBL17431205 0.81 AHR (0.41) GPR3MAPTALDH1A1POLBTDP1
SCHEMBL17431201 0.80 MAPT (0.42) GPR3MAPTALDH1A1POLBTDP1
SCHEMBL17431197 0.77 GPR3 (0.37) GPR3MAPTALDH1A1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10566546-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-02-18 — — US disclosed
US-20160013422-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-01-14 — — US disclosed
US-20160013422-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160013422-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OXER1, NR4A3, OXSR1 GPR3 164/4885MAPT 4272/4885ALDH1A1 2467/4885
US-10566546-B2 Organic electroluminescent materials and devices OXER1, NR4A3, OXSR1 GPR3 164/4885MAPT 4272/4885ALDH1A1 2467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback